Your comprehensive pharmaceutical information center for checking drug interactions, managing medications, and accessing reliable pharmaceutical data.
Check for potential interactions between multiple medications, supplements, and foods. Our comprehensive database includes prescription drugs, over-the-counter medications, and herbal supplements.
Add custom medications, herbal remedies, or supplements not found in our database. Track interactions with your existing medications and maintain a complete profile.
Create and manage your personal medication profile. Keep track of all your prescriptions, over-the-counter medications, and supplements in one place.
Access our comprehensive database of peer-reviewed research, clinical studies, and verified pharmaceutical information to make informed decisions about your medications.
Check interactions with over-the-counter medications.
Check interactions with herbal supplements.
Check interactions between medications and food.
| Medications | Date | Severity | Actions |
|---|---|---|---|
|
Lisinopril + Potassium supplements
ACE inhibitor + Supplement
|
2025-04-03 | High | |
|
Warfarin + Aspirin
Anticoagulant + NSAID
|
2025-04-02 | High | |
|
Simvastatin + Grapefruit juice
Statin + Food
|
2025-04-01 | Medium | |
|
Levothyroxine + Calcium supplements
Thyroid hormone + Supplement
|
2025-03-30 | Medium | |
|
Metformin + Vitamin B12
Antidiabetic + Vitamin
|
2025-03-28 | Low |
You haven't saved any interactions yet. When you save an interaction, it will appear here for future reference.
Your medication history will be displayed here.
Information about herbal supplements will be displayed here.
Information about Ayurvedic medicines will be displayed here.
Access our comprehensive database of peer-reviewed research, clinical studies, and verified pharmaceutical information.
This meta-analysis of 13 randomized controlled trials involving 91,140 participants found that statin therapy was associated with a 9% increased risk of incident diabetes.
A randomized, double-blind, placebo-controlled trial of St. John's Wort extract in 340 patients with major depression found it to be as effective as standard antidepressants with fewer side effects.
A 10-year follow-up study of 12,500 patients taking ACE inhibitors found sustained blood pressure control with minimal long-term adverse effects compared to other antihypertensive medications.
Use our verification tools to check the reliability and scientific backing of medication information.
Check if a medication is FDA approved, including approval date, indications, and any black box warnings.
Evaluate the strength of clinical evidence supporting medication efficacy and safety claims.
Analyze the credibility of information sources using our multi-factor verification system.
Fact-check specific claims about medications against peer-reviewed scientific literature.
Browse and search clinical studies related to medications, supplements, and treatments.
Currently recruiting and active clinical trials.
| Study Title | Condition | Phase | Status | Actions |
|---|---|---|---|---|
| Novel SGLT2 Inhibitor for Type 2 Diabetes | Type 2 Diabetes | Phase 3 | Recruiting | |
| Comparative Efficacy of Antihypertensive Medications | Hypertension | Phase 4 | Active | |
| Ginkgo Biloba for Cognitive Function | Mild Cognitive Impairment | Phase 2 | Recruiting |
Recently completed clinical trials.
| Study Title | Condition | Phase | Completion Date | Actions |
|---|---|---|---|---|
| Long-term Safety of PCSK9 Inhibitors | Hypercholesterolemia | Phase 3 | January 2025 | |
| Efficacy of Curcumin for Inflammatory Conditions | Osteoarthritis | Phase 2 | December 2024 | |
| Novel Anticoagulant Comparison Study | Atrial Fibrillation | Phase 4 | February 2025 |
Published results from clinical studies.
This head-to-head trial compared the efficacy and safety of three GLP-1 receptor agonists in 1,200 patients with type 2 diabetes over 52 weeks.
A randomized, double-blind, placebo-controlled trial of standardized ashwagandha extract in 120 adults with moderate stress showed significant reductions in stress and anxiety scores.
A 5-year follow-up study of 8,500 patients with type 2 diabetes and established cardiovascular disease found that SGLT2 inhibitors reduced the risk of major adverse cardiovascular events by 14%.